Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maaike E Ressing

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasionMartin Rowe, Britt Glaunsinger, Daphne van Leeuwen, et al.
Plos Pathogens|January 3, 2009
The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradationJianmin Zuo, Andrew Currin, Bryan D Griffin, et al.
Journal of Virology|June 15, 2012
The "Bridge" in the Epstein-Barr virus alkaline exonuclease protein BGLF5 contributes to shutoff activity during productive infectionDaniëlle Horst, Wim P Burmeister, Ingrid G J Boer, et al.
Journal of Virology|October 21, 2011
Epstein-Barr virus isolates retain their capacity to evade T cell immunity through BNLF2a despite extensive sequence variationDaniëlle Horst, Scott R Burrows, Derek Gatherer, et al.
Molecular Immunology|October 3, 2017
Human B cells fail to secrete type I interferons upon cytoplasmic DNA exposureAnna M Gram, Chenglong Sun, Sanne L Landman, et al.
The Journal of General Virology|December 16, 2014
Silencing the shutoff protein of Epstein-Barr virus in productively infected B cells points to (innate) targets for immune evasionMichiel van Gent, Anna M Gram, Ingrid G J Boer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2009
Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentationDaniëlle Horst, Daphne van Leeuwen, Nathan P Croft, et al.
Molecular Immunology|February 5, 2011
Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesvirusesMarieke C Verweij, Maaike E Ressing, Wilco Knetsch, et al.
Bioconjugate Chemistry|June 9, 2020
Conditionally Controlling Human TLR2 Activity via Trans-Cyclooctene Caged LigandsMichel J van de Graaff, Timo Oosenbrug, Mikkel H S Marqvorsen, et al.
Plos Pathogens|May 23, 2012
CD200 receptor controls sex-specific TLR7 responses to viral infectionGuruswamy Karnam, Tomasz P Rygiel, Matthijs Raaben, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasionMartin Rowe, Britt Glaunsinger, Daphne van Leeuwen, et al.
Plos Pathogens|January 3, 2009
The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradationJianmin Zuo, Andrew Currin, Bryan D Griffin, et al.
Journal of Virology|June 15, 2012
The "Bridge" in the Epstein-Barr virus alkaline exonuclease protein BGLF5 contributes to shutoff activity during productive infectionDaniëlle Horst, Wim P Burmeister, Ingrid G J Boer, et al.
Journal of Virology|October 21, 2011
Epstein-Barr virus isolates retain their capacity to evade T cell immunity through BNLF2a despite extensive sequence variationDaniëlle Horst, Scott R Burrows, Derek Gatherer, et al.
Molecular Immunology|October 3, 2017
Human B cells fail to secrete type I interferons upon cytoplasmic DNA exposureAnna M Gram, Chenglong Sun, Sanne L Landman, et al.
The Journal of General Virology|December 16, 2014
Silencing the shutoff protein of Epstein-Barr virus in productively infected B cells points to (innate) targets for immune evasionMichiel van Gent, Anna M Gram, Ingrid G J Boer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2009
Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentationDaniëlle Horst, Daphne van Leeuwen, Nathan P Croft, et al.
Molecular Immunology|February 5, 2011
Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesvirusesMarieke C Verweij, Maaike E Ressing, Wilco Knetsch, et al.
Bioconjugate Chemistry|June 9, 2020
Conditionally Controlling Human TLR2 Activity via Trans-Cyclooctene Caged LigandsMichel J van de Graaff, Timo Oosenbrug, Mikkel H S Marqvorsen, et al.
Plos Pathogens|May 23, 2012
CD200 receptor controls sex-specific TLR7 responses to viral infectionGuruswamy Karnam, Tomasz P Rygiel, Matthijs Raaben, et al.
Pageof 6